Evexia Lifecare Ltd Plans Major Expansion; To Enter Into Bullion Trading

Vadodara (Gujarat) [India], October 11: BSE listed (524444), Evexia Lifecare Limited has received initial plant layout permission from FDA to setup Active Pharmaceutical Ingredient (API) manufacturing plant of Isometamidium (Isometa) in addition to the current ongoing commercial activity, mainly used for the rare diseases in cattle, buffalo, goat, dogs, etc. Very few companies are manufacturing the said API in India and worldwide. The Company has completed the application process for environment clearance with the concerned government authority and has procured all the required plant and machinery at the Vadodara plant location. Once the Company receives the Environment Clearance (EC) from the concerned Government Authorities, the installation and production work will commence.

Further, the Board of Directors of one of the subsidiary companies, namely Kavit Trading Private Limited, where Evexia holds 70% of the shareholding, has approved the business of direct buying of bullion from the Banks and selling in the market. The said subsidiary company has approached bankers for the opening of Bullion Accounts with them. This new business will boost the revenue of the said subsidiary company and consequently improve the Company’s consolidated financials.

Apart from the ISOMETA API product, Evexia Lifecare Limited is also planning to manufacture intermediate, mainly used for anti-diabetic and heart diseases, at Vadodara based plant location. The Research & Development (R & D) team is at the final stage of five more products that the Company may launch by November 2021.

The Company is at an advanced stage of acquiring Akola (Maharashtra) based existing plant of one of the manufacturers of ISOMETA API, which will increase production capacity and profitability.

The Company’s vision is to enter into formulation by January 2022, which will give a push to the Company’s growth for the long term. The R & D team has already started work for the formulation plant, looking into the opportunity and available market in India and across the globe.

The Company has started its new branch at Hyderabad location to trade pharmaceutical chemicals, and the same will likely contribute Rs. 25-30 Cr turnover per year.

For the above all expansion activities, the Company will manage the funds internally, and the board is not expecting any external borrowings.

Comments are closed.

Business

An Unforgettable Evening: EO Noida’s 4th President’s Gala Shines Bright

Noida (Uttar Pradesh), July 13: On 6th July, EO Noida’s President Gala at the ITC Grand Bharat in Gurgaon. Drawing attention as a highlight on the social calendar, the annual gala combined futuristic elegance with avant-garde flair, creating a sensory feast for attendees. The evening commenced with a gourmet lunch and an energetic salsa workshop, […]

Read More
Business

Celebrate the Bond of Love with Thoughtful Rakhi Gifts from Rakhi.com

Rakhi.com launches latest rakhi collection and gift hampers New Delhi (India), July 12 : As the auspicious festival of Raksha Bandhan is coming soon, Rakhi.com is all set with their latest rakhi collection, celebrating the bond between siblings. Founded with a vision to enhance the essence of sibling love, they offer heartfelt rakhi gifts hampers embodying Raksha Bandhan’s spirit.  […]

Read More
Business

Aeterna Shower Sliding System by Hafele

New Delhi (India) July 12 : Sliding solutions optimise space and deliver enhanced functionality and aesthetics in any area of home. Introducing a shower sliding system transforms your daily routine with a space-saving, convenient solution. Meticulously crafted with precision and attention to details, Hafele’s new Aeterna Shower Sliding System exudes state-of-the-art luxury. “Aeterna,” which in […]

Read More